Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients
- PMID: 34376481
- DOI: 10.1126/sciimmunol.abg5021
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients
Abstract
To understand how a protective immune response against SARS-CoV-2 develops over time, we integrated phenotypic, transcriptional and repertoire analyses on PBMCs from mild and severe COVID-19 patients during and after infection, and compared them to healthy donors (HD). A type I IFN-response signature marked all the immune populations from severe patients during the infection. Humoral immunity was dominated by IgG production primarily against the RBD and N proteins, with neutralizing antibody titers increasing post infection and with disease severity. Memory B cells, including an atypical FCRL5+ T-BET+ memory subset, increased during the infection, especially in patients with mild disease. A significant reduction of effector memory, CD8+ T cells frequency characterized patients with severe disease. Despite such impairment, we observed robust clonal expansion of CD8+ T lymphocytes, while CD4+ T cells were less expanded and skewed toward TCM and TH2-like phenotypes. MAIT cells were also expanded, but only in patients with mild disease. Terminally differentiated CD8+ GZMB+ effector cells were clonally expanded both during the infection and post-infection, while CD8+ GZMK+ lymphocytes were more expanded post-infection and represented bona fide memory precursor effector cells. TCR repertoire analysis revealed that only highly proliferating T cell clonotypes, which included SARS-CoV-2-specific cells, were maintained post-infection and shared between the CD8+ GZMB+ and GZMK+ subsets. Overall, this study describes the development of immunity against SARS-CoV-2 and identifies an effector CD8+ T cell population with memory precursor-like features.
Copyright © 2021, American Association for the Advancement of Science.
Similar articles
-
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.J Infect Dis. 2021 Jul 2;224(1):39-48. doi: 10.1093/infdis/jiab159. J Infect Dis. 2021. PMID: 33755725 Free PMC article.
-
Distinct immune memory induced by SARS-CoV-2 in convalescent liver transplant recipients.Front Immunol. 2025 Apr 2;16:1420150. doi: 10.3389/fimmu.2025.1420150. eCollection 2025. Front Immunol. 2025. PMID: 40242765 Free PMC article.
-
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.Front Immunol. 2021 May 26;12:665329. doi: 10.3389/fimmu.2021.665329. eCollection 2021. Front Immunol. 2021. PMID: 34122423 Free PMC article.
-
Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.Mol Cells. 2021 Jun 30;44(6):401-407. doi: 10.14348/molcells.2021.0079. Mol Cells. 2021. PMID: 34120892 Free PMC article. Review.
-
Age-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19.Front Immunol. 2021 Mar 29;12:636118. doi: 10.3389/fimmu.2021.636118. eCollection 2021. Front Immunol. 2021. PMID: 33854506 Free PMC article. Review.
Cited by
-
Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2.Vaccines (Basel). 2022 Nov 24;10(12):1997. doi: 10.3390/vaccines10121997. Vaccines (Basel). 2022. PMID: 36560407 Free PMC article.
-
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences.Front Immunol. 2023 Aug 17;14:1244556. doi: 10.3389/fimmu.2023.1244556. eCollection 2023. Front Immunol. 2023. PMID: 37662901 Free PMC article. Review.
-
MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates.Nat Commun. 2024 Oct 17;15(1):8959. doi: 10.1038/s41467-024-52863-9. Nat Commun. 2024. PMID: 39420177 Free PMC article.
-
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature.Vaccines (Basel). 2024 Sep 14;12(9):1051. doi: 10.3390/vaccines12091051. Vaccines (Basel). 2024. PMID: 39340081 Free PMC article. Review.
-
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.Immunity. 2022 Feb 8;55(2):366-375. doi: 10.1016/j.immuni.2022.01.015. Immunity. 2022. PMID: 35139354 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous